Imprimis Pharmaceuticals, Inc. (IMMY) CEO Mark Baum on Q3 2018 Results - Earnings Call Transcript
Related Biotechnology, Pharmaceutical and Healthcare News
Original Article: Imprimis Pharmaceuticals, Inc. (IMMY) CEO Mark Baum on Q3 2018 Results - Earnings Call Transcript
NEXT ARTICLE
More From BioPortfolio on "Imprimis Pharmaceuticals, Inc. (IMMY) CEO Mark Baum on Q3 2018 Results - Earnings Call Transcript"